PDCD1 and cancer: Some well-known suitable targets for cancer immunotherapy include cytotoxic T lymphocyte antigen-4 and programmed cell death-1 (PD-1).[1,2] PD-1 is one of the significant immunosuppressive molecules and the most well-established co-inhibitory regulators suppressing proliferations and cytokine’s productions of T-cells.